BRAND_ANALYSIS #ROCHE HEALTH & PHARMA #16 OF 26 IN HEALTH & PHARMA ALIGNED

Roche

· Private · Updated 09 Sep 2026 07:29 UTC
#579 of 1208 overall by tension · #16 of 26 in Health & Pharma
13 Aligned
The Balanced
Analysis

Pharma giant at C=53, B=66, sentiment 0.70. Roche's business success is partly immune from cultural cycles—it makes cancer drugs, not iPhones. High sentiment despite invisibility suggests market-facing divisions are maintaining narrative control.

IN THE NEWS (94 articles this week)
Why Roche is 'really excited' about a UCN2 analog for obesity after seeing preclinical data - fiercebiotech.com
Roche and NVIDIA deploy the pharmaceutical industry’s largest artificial intelligence factory - 2minutemedicine.com
Roche sweeps neurology corporate reputation rankings once again - Fierce Pharma
Cultural Score
53 / 100
Business Score
66 / 100
TREND
TENSION▁▁▁▁▁▁▂▁▁▁▁▁▁▁
CULTURAL▄▄▄▄▄▄▄▄▄▄▄▄▄▄
BUSINESS▅▅▅▅▅▅▆▅▅▅▅▅▅▅
TREND CHART
Loading...
CULTURAL BREAKDOWN
Wikipedia Momentum 15/40
News Presence 39/35
Search InterestRedistributed to other dimensions
BUSINESS BREAKDOWN
Stock Momentum 0/30
Market Position 0/25
Revenue Growth 0/25
Earnings Health 0/20
BRANDS LIKE THIS
UnitedHealthcare
C:50 B:64 T:14
Epic Systems
C:50 B:62 T:12
Calm
C:53 B:63 T:10
Illumina
C:53 B:63 T:10
Moderna
C:57 B:67 T:10
SHARE
Roche's tension is 13. Commerce outpacing culture. sociologyofcapitalism.com/brand/roche
SHARE ON X
EMBED
<iframe src="https://sociologyofcapitalism.com/embed/roche.html" width="320" height="200" frameborder="0"></iframe>
Data: Wikipedia Pageviews, Google News RSS, AI Sentiment
All scores approximate. Updated daily.
Sociology of Capitalism
Mike Litman